Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Petros Pharmaceuticals (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the-counter (OTC) drug development programs, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The event is scheduled for September 9-11, 2024 at the Lotte New York Palace Hotel.
Fady Boctor, President and Chief Commercial Officer of Petros Pharmaceuticals, will present a corporate overview on September 9, 2024. The presentation will be available on-demand starting at 7:00 AM ET. Interested investors can register for the conference online to access the presentation. Additionally, Mr. Boctor will be available for one-on-one meetings with registered conference investors.
Petros Pharmaceuticals (NASDAQ:PTPI), un'azienda focalizzata sull'espansione dell'accesso dei consumatori ai farmaci attraverso programmi di sviluppo di farmaci da banco (OTC), ha annunciato la sua partecipazione alla 26a Conferenza Annuale di Investimento Globale H.C. Wainwright. L'evento si svolgerà dal 9 all'11 settembre 2024 presso il Lotte New York Palace Hotel.
Fady Boctor, Presidente e Direttore Commerciale di Petros Pharmaceuticals, presenterà una panoramica aziendale il 9 settembre 2024. La presentazione sarà disponibile on-demand a partire dalle 7:00 AM ET. Gli investitori interessati possono registrarsi online per la conferenza per accedere alla presentazione. Inoltre, il Sig. Boctor sarà disponibile per incontri individuali con gli investitori registrati alla conferenza.
Petros Pharmaceuticals (NASDAQ:PTPI), una empresa centrada en ampliar el acceso de los consumidores a medicamentos a través de programas de desarrollo de medicamentos de venta libre (OTC), ha anunciado su participación en la 26ª Conferencia Anual Global de Inversión H.C. Wainwright. El evento está programado para el 9 al 11 de septiembre de 2024 en el Lotte New York Palace Hotel.
Fady Boctor, Presidente y Director Comercial de Petros Pharmaceuticals, presentará una visión general de la empresa el 9 de septiembre de 2024. La presentación estará disponible bajo demanda a partir de las 7:00 AM ET. Los inversores interesados pueden registrarse en línea para la conferencia y acceder a la presentación. Además, el Sr. Boctor estará disponible para reuniones individuales con los inversores registrados para la conferencia.
페트로스 제약 (NASDAQ:PTPI), 소비자가 일반의약품(OTC) 개발 프로그램을 통해 약물에 대한 접근성을 확대하는 데 중점을 둔 회사는 H.C. 웨인라이트 제26회 연례 글로벌 투자 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2024년 9월 9일부터 11일까지 롯데 뉴욕 팰리스 호텔에서 개최됩니다.
페트로스 제약의 사장 겸 최고 상업 책임자인 파디 복토르(Fady Boctor)는 2024년 9월 9일에 기업 개요를 발표할 예정입니다. 발표는 오전 7시 ET부터 주문형으로 제공될 것입니다. 관심 있는 투자자들은 온라인으로 컨퍼런스에 등록하여 발표에 접근할 수 있습니다. 또한 복토르 씨는 등록된 투자자들과의 일대일 회의도 가능할 것입니다.
Petros Pharmaceuticals (NASDAQ:PTPI), une entreprise axée sur l'élargissement de l'accès des consommateurs aux médicaments grâce à des programmes de développement de médicaments en vente libre (OTC), a annoncé sa participation à la 26ème Conférence Annuelle Mondiale d'Investissement H.C. Wainwright. L'événement est prévu du 9 au 11 septembre 2024 à l'Hôtel Lotte New York Palace.
Fady Boctor, Président et Directeur Commercial de Petros Pharmaceuticals, présentera un aperçu de l'entreprise le 9 septembre 2024. La présentation sera disponible à la demande à partir de 7h00 ET. Les investisseurs intéressés peuvent s'inscrire en ligne pour la conférence afin d'accéder à la présentation. De plus, M. Boctor sera disponible pour des réunions individuelles avec les investisseurs inscrits à la conférence.
Petros Pharmaceuticals (NASDAQ:PTPI), ein Unternehmen, das sich darauf konzentriert, den Zugang der Verbraucher zu Medikamenten durch Programme zur Entwicklung von rezeptfreien (OTC) Arzneimitteln zu erweitern, hat seine Teilnahme an der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright angekündigt. Die Veranstaltung findet vom 9. bis 11. September 2024 im Lotte New York Palace Hotel statt.
Fady Boctor, Präsident und Chief Commercial Officer von Petros Pharmaceuticals, wird am 9. September 2024 eine Unternehmensübersicht präsentieren. Die Präsentation wird ab 7:00 AM ET on-demand verfügbar sein. Interessierte Investoren können sich online für die Konferenz registrieren, um auf die Präsentation zuzugreifen. Darüber hinaus wird Herr Boctor für Einzelgespräche mit registrierten Investoren der Konferenz zur Verfügung stehen.
- None.
- None.
NEW YORK, NY / ACCESSWIRE / September 3, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- counter ("OTC") drug development programs, announces today that Fady Boctor, President and Chief Commercial Officer, will present a corporate overview at the H.C. Wainwright 26th Annual Global Investment Conference. The conference is being held on September 9 - 11, 2024 at the Lotte New York Palace Hotel.
Presentation Date: September 9, 2024
Time: Available on-demand starting at 7:00 AM ET
Investors who wish to listen to the Company's presentation can do so by registering for the conference here: https://hcwevents.com/annualconference/
Mr. Boctor will be available for one-on-one meetings with registered investors of the conference.
About Petros Pharmaceuticals
Petros Pharmaceuticals, Inc. is committed to the goal of becoming a leading innovator in the emerging self-care market driving expanded access to key prescription pharmaceuticals as OTC treatment options. Currently, Petros is pursuing increased access for its flagship prescription ED therapy, STENDRA® (avanafil), via potential OTC designation (see important safety information below.) If ultimately approved by the FDA for OTC access, STENDRA® (avanafil) may be the first in its class to achieve this marketing status, also establishing company know how as a potentially proven platform for other prospective prescription therapeutics.
Contacts:
Investors:
CORE IR
ir@petrospharma.com
Media:
Jules Abraham
CORE IR
917-885-7378
pr@coreir.com
SOURCE: Petros Pharmaceuticals, Inc.
View the original press release on accesswire.com
FAQ
When is Petros Pharmaceuticals (PTPI) presenting at the H.C. Wainwright Global Investment Conference?
Who will be presenting for Petros Pharmaceuticals (PTPI) at the H.C. Wainwright conference?
Where is the H.C. Wainwright 26th Annual Global Investment Conference being held?
How can investors access Petros Pharmaceuticals' (PTPI) presentation at the H.C. Wainwright conference?
Will Petros Pharmaceuticals (PTPI) be available for one-on-one meetings at the H.C. Wainwright conference?
